1,2-Dichloroethane → HCID 90041838, compound
Reaction equation
[CH3:1][C:2]1[CH:3]=[C:4]([C:19]2[CH:24]=[CH:23][CH:22]=[C:21]([C:25]([OH:27])=O)[CH:20]=2)[CH:5]=[C:6]([NH:8][C:9]2[N:14]=[C:13]([C:15]([F:18])([F:17])[F:16])[CH:12]=[CH:11][N:10]=2)[CH:7]=1.[CH3:28][S:29]([NH2:32])(=[O:31])=[O:30].C(Cl)CCl.C(N(CC)CC)C>CN(C1C=CN=CC=1)C.CN(C=O)C>[CH3:1][C:2]1[CH:3]=[C:4]([C:19]2[CH:24]=[CH:23][CH:22]=[C:21]([C:25]([NH:32][S:29]([CH3:28])(=[O:31])=[O:30])=[O:27])[CH:20]=2)[CH:5]=[C:6]([NH:8][C:9]2[N:14]=[C:13]([C:15]([F:16])([F:17])[F:18])[CH:12]=[CH:11][N:10]=2)[CH:7]=1Participants
Procedure
A cloudy solution of 3′-methyl-5′-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}biphenyl-3-carboxylic acid (100 mg, 0.222 mmol), methanesulfonamide (24.3 mg, 0.256 mmol), DMAP (5.4 mg, 0.044 mmol), EDC (59.7 mg, 0.311 mmol), and triethylamine (0.043 mL, 0.31 mmol) in DMF (4 mL) was stirred for 14 hours at room temperature. The reaction mixture was purified directly via reverse phase HPLC (CH3CN:H2O with 0.1% TFA) to give 3′-methyl-N-(methylsulfonyl)-5′-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}biphenyl-3-carboxamide. MS ESI calc'd. for C20H18F3N4O3S [M+H]+ 451, found 451. 1H NMR (500 MHz, DMSO-d6) δ 12.26 (s, 1H), 10.26 (s, 1H), 8.82 (d, J=4.9 Hz, 1H), 8.18 (s, 1H), 7.95 (s, 1H), 7.90 (d, J=7.8 Hz, 1H), 7.87 (d, J=7.9 Hz, 1H), 7.61 (t, J=7.8 Hz, 1H), 7.57 (s, 1H), 7.26 (d, J=5.0 Hz, 1H), 7.24 (s, 1H), 3.39 (s, 3H), 2.38 (s, 3H).
Workup
- customThe reaction mixture was purified directly via reverse phase HPLC (CH3CN:H2O with 0.1% TFA)
Sources & evidence
- ORD record
- ord-e3ce8087cf5340a8b68c2a2eba385655
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09353066B2
Reaction notes
Loading…